phys pharm - Asthma: Flashcards
asthma =
chronic inflammatory disorder of the airways associated with smooth muscle hyperresponsiveness and obstruction
= wheezing, breathlessness, chest tightness, coughing
bronchial asthma =
recurrent, ‘reversible’ obstruction of the airways in response to a stimulus (e.g. cold air, exercise, pollen, dust) that is innocuous to a non-asthmatic individual
chronic asthma =
irreversible changes in airways calibre through hypertrophy and hyperplasia of the smooth muscle
= hypersecretion of mucus
= thickened basement membrane
= increased volume of smooth muscle
allergen response in asthma:
During an asthma attack the airways narrow and the sufferer has problems breathing out. This respiratory difficulty can be quantified by measuring FEV1 (Forced Expiratory Volume in 1 second)
after a few minuites of attack = early phase
further effects hours later = late phase
Modern Treatment Strategies in Asthma:
- Prophylaxis
2. Symptomatic Relief
- Prophylaxis:
Prevent/reduce inflammation using anti-inflammatory agents,
e.g. using corticosteroids (beclomethasone
OR fluticasone)
Problems associated with chronic corticosteroid dosing…
Cushing’s syndrome
Thinning of skin / easy bruising / oedema / ulceration
Poor wound-healing / increased risk of infection
Increased appetite / increased abdominal fat / muscle wasting
Negative Ca2+ balance/osteoporosis
- Symptomatic Relief
Rapid reversal of bronchoconstriction (using β2-selective adrenoceptor agonists)
E.G. salbutamol, terbutaline, salmeterol
β2-selective adrenoceptor agonists
- relax bronchoconstriction irrespective of the cause
- Inhibit mucus secretion and stimulate mucus clearance
- Decrease tissue oedema
- possess some anti-inflammatory activity
Airways Smooth Muscle Contraction controlled by …
acetylcholine
histamine
leukotrienes
These agents interact with specific G protein-coupled receptors in
the smooth muscle to cause Ca2+
influx = Ca2+/calmodulin-dependent activation of
myosin light chain kinase and myosin phosphorylation to
promote contraction
Airways Smooth Muscle Relaxation…
β2-adrenoceptor activation causes adenylyl cyclase activation (via a Gs protein) to increase cyclic AMP/cyclic AMP-dependent protein kinase activity leading to:
decrease in [Ca2+] (through activation of Ca2+ efflux pathways and/or inhibition of Ca2+ influx pathways)
inhibition of myosin phosphorylation by myosin light chain kinase
promotion of myosin dephosphorylation
Therefore, if a β2-adrenoceptor agonist is delivered to the airways it will relax the airways smooth muscle
Long-acting β2-adrenoceptor agonists…
e.g. salmeterol
= may offer 24 hour prophylaxis against asthma attack
poorly effective in revering acute asthma attack but prevents bronchospasm
The long-acting = due to the long hydrophobic tail of the molecule that acts like a leash, tethering the molecule to the β2-adrenoceptor
Most common asthma therapy currently is..
combined inhaled LABA + corticosteroid
e.g.
SALMETEROL + FLUTICASONE